Creating user-friendly tools to discover new drugs
Developing and Applying Accessible Computational Technologies for the Design of Small-Molecule Ligands
['FUNDING_OTHER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-10765144
This study is all about using computer technology to find new medicines that could help treat diseases like cancer, making it easier for scientists to discover and improve potential treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10765144 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the process of drug discovery by developing accessible computational technologies that can predict which small molecules may have therapeutic potential. By using computer-aided drug discovery (CADD), the team aims to identify new bioactive molecules and enhance their properties to make them more effective as treatments. The research involves innovative modeling techniques to understand how these molecules interact with proteins related to various diseases, including cancer. Ultimately, the goal is to provide the scientific community with better tools to develop new therapies for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that could benefit from new drug therapies, particularly those related to cancer and metabolic disorders.
Not a fit: Patients with conditions that are not related to the diseases being targeted by this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and accessible treatments for various diseases, including cancer.
How similar studies have performed: Previous research in computer-aided drug discovery has shown promise in improving drug development processes, indicating that this approach could yield significant advancements.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DURRANT, JACOB D — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: DURRANT, JACOB D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers